Sarah Davies, DDS
Oral & Maxillofacial Surgery · Tarentum, PANPI 1336222389
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (50.3%), food and beverage and gifts — rather than concentrated in one kind of arrangement. Zimmer Biomet accounts for 67.5% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2019 at $2,202 and has fallen 75.3% since, to $545 in 2025.
Across 29 payments — averaging $104.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Zimmer Biomet$2K
- Zimvie Inc.$546
- Biohorizons Implant Systems Inc.$198
- Envista Holdings Corporation$109
- Orthofix Medical, Inc.$66
- Straumann USA LLC$50
- plus $20 from 1 others
What the payments were for
- Travel & lodging$1,53150%
- Food & beverage$1,46348%
- Gifts$502%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Zimmer Biomet | 12 | $2,056 |
| Zimvie Inc. | 7 | $546 |
| Biohorizons Implant Systems Inc. | 6 | $198 |
| Envista Holdings Corporation | 1 | $109 |
| Orthofix Medical, Inc. | 1 | $66 |
| Straumann USA LLC | 1 | $50 |
| Boston Scientific | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Diem2$1,552
- TSX Implants$500
- Tapered Screw$229
- KAVO OP30200300$109
- Bellatek$102
How this compares
$3,045 in reported general payments places this provider in the 85th percentile of 369 oral & maxillofacial surgery providers in Pennsylvania.
See all oral & maxillofacial surgery providers in Pennsylvania →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Chlorhexidine Gluconate | 100 | $414 |
| Amoxicillin | 150 | $367 |
| Ibuprofen | 33 | $97 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 13 | $80 |
| Azithromycin | 18 | $67 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 30 | $62 |
| IbuIbuprofen | 12 | $36 |
Paid to pharmacies, not to this prescriber.
Other oral & maxillofacial surgery in Tarentum
- Mark OchsPittsburgh$449K
- Ankur JohriAllentown$98K
- Richard BauerWexford$95K
- Joseph LeonettiPaoli$88K
- Larry CunninghamPitsburgh$83K
- Neeraj PanchalPhiladelphia$73K
- Eric GranquistPhiladelphia$65K
- Michael HartmanMechanicsburg$50K
- Bernard CostelloPittsburgh$44K
- Thomas HelfstStroudsburg$42K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.